Treating COVID-19 infections

Options for treating Covid-19 infections is yet another area where the landscape is rapidly changing, says a leading expert on the pandemic.

Speaking last week on the Going Viral podcast, infectious diseases physician and clinical microbiologist, Associate Professor Paul Griffin said there is a wealth of research currently underway into treatments for the infection and it is likely the current recommendations will soon change.

To date we have had some very good monoclonal antibody therapies, given intravenously that have proven effective in treating Covid-19 infections.

These include, sotrovimab which is given to high-risk individuals in the first few days of their Covid-19 infection. In this context, high-risk individuals have been unvaccinated patients or those unable to mount an immune response to the vaccine.

Send this to a friend